OZENOXACIN
| Brand name | XEPI |
|---|---|
| Active ingredient | OZENOXACIN |
| Strength | 1% |
| Dosage form | CREAM |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | December 2017 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9180200 | January 2032 | product |
| 9399014 | December 2029 | use U-805 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.